Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women

被引:175
作者
Somekawa, Y
Chiguchi, M
Ishibashi, T
Aso, T
机构
[1] Toride Kyodo Gen Hosp, Dept Obstet & Gynecol, Toride, Ibaraki 3020022, Japan
[2] Tokyo Med & Dent Univ, Dept Obstet & Gynecol, Tokyo, Japan
关键词
D O I
10.1016/S0029-7844(00)01080-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the effects of dietary isoflavones in soy products on menopausal symptoms, lipid profiles, and bone mineral densities in postmenopausal Japanese women. Methods: We estimated the daily intakes of isoflavones in the diets of 478 postmenopausal Japanese women who reported soy consumption. We recorded serum values of fasting total cholesterol, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and apolipoproteins. Bone mineral density was measured at the lumbar spine (L2-L4) by dual energy x-ray absorptiometry. Women were assigned to two groups according to years since menopause (early and late postmenopausal groups), and each group was subcategorized into four groups according to dietary isoflavone intake. Relationships between isoflavone intake, menopausal symptoms, lipid profiles, and bone mineral density were examined in each group. Results: The mean estimated intake of isoflavones among 478 women was 54.3 mg/day. With stepwise regression analysis we found that weight and years since menopause were significant independent predictors of bone mineral density. Bone mineral densities adjusted to years since menopause and weight were significantly different in the highest intake compared with lowest intake category (P < .001) within the early and late postmenopausal groups. In the early postmenopausal group, significant differences were found in palpitation and backaches between the high and low intake categories but were not significant in the late postmenopausal group. Conclusion: High consumption of soy products is associated with increased bone mass in postmenopausal women and might be useful for preventing hypoestrogenic effects. (C) 2001 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 23 条
[1]   Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years [J].
Adami, S ;
Bufalino, L ;
Cervetti, R ;
DiMarco, C ;
DiMunno, O ;
Fantasia, L ;
Isaia, GC ;
Serni, U ;
Vecchiet, L ;
Passeri, M ;
Castiglione, GN ;
Gardini, F ;
Letizia, G ;
Occhipinti, L ;
Pardini, N ;
Agamennone, M ;
Sciolla, A ;
Matucci, A ;
Riboldi, R ;
Costi, D ;
DallAglio, E ;
Pedrazzoni, M .
OSTEOPOROSIS INTERNATIONAL, 1997, 7 (02) :119-125
[2]  
BARNES S, 1995, J CELL BIOCHEM, P181
[3]   BIOLOGICAL EFFECTS OF ISOFLAVONES IN YOUNG-WOMEN - IMPORTANCE OF THE CHEMICAL-COMPOSITION OF SOYBEAN PRODUCTS [J].
CASSIDY, A ;
BINGHAM, S ;
SETCHELL, K .
BRITISH JOURNAL OF NUTRITION, 1995, 74 (04) :587-601
[4]   TOFU AND SOY DRINKS CONTAIN PHYTOESTROGENS [J].
DWYER, JT ;
GOLDIN, BR ;
SAUL, N ;
GUALTIERI, L ;
BARAKAT, S ;
ADLERCREUTZ, H .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1994, 94 (07) :739-743
[5]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY OF ISOFLAVONOIDS AND COUMESTROL FROM HUMAN URINE [J].
FRANKE, AA ;
CUSTER, LJ .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1994, 662 (01) :47-60
[6]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[7]   EFFECTS OF IPRIFLAVONE ADMINISTRATION ON BONE MASS AND METABOLISM IN OVARIECTOMIZED WOMEN [J].
GAMBACCIANI, M ;
SPINETTI, A ;
CAPPAGLI, B ;
TAPONECO, F ;
FELIPETTO, R ;
PARRINI, D ;
CAPPELLI, N ;
FIORETTI, P .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1993, 16 (05) :333-337
[8]  
*GOV JAP STAT BUR, 1987, ANN REP FAM INC EXP, P328
[9]  
KAO SC, 1995, CHIN MED J, V55, P209
[10]   CONTESTED MEANINGS OF THE MENOPAUSE [J].
LOCK, M .
LANCET, 1991, 337 (8752) :1270-1272